People · Operator
Named in public records as an officer, director or promoter · active 2022–2024 · Medical Devices, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Covira Surgical, Inc. | — | Medical Devices | Pre-Seed | $275K | $3.5M | 2022 |
| 32 Biosciences, Inc. | — | Biotechnology | Pre-Seed | $160K | $791K | 2024 |
Peter Farmakis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter Farmakis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Yoor | 2 | 2 |
| Eugene C. Chang | 1 | 1 |
| Joseph Francis Pierre | 1 | 1 |
| John C. Alverdy | 1 | 1 |
| John Alverdy | 1 | 1 |
| Jamie Contreras | 1 | 1 |
| Jaime Contreras | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.